Overview
- 33 inspections across 33 sites are on record.
- 16 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-07-02.
At a glance
Inspections
33
Sites
33
Observations
16
Career since
Oct 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Dayan K. Gandhi, M.D. | 2 Jul 2026 | Human Drugs | View 483 → |
| David Gary Lott, MD | 11 Jun 2026 | Biologics | |
| AnaptysBio | 29 Apr 2026 | Human Drugs | View 483 → |
| Aaron R. Mangold, M.D. | 26 Mar 2026 | Human Drugs | |
| Joanna Van, M.D. | 3 Mar 2026 | Human Drugs |
Sites inspected
Dayan K. Gandhi, M.D.Granada Hills, United States1 insp.
David Gary Lott, MDPhoenix, United States1 insp.
AnaptysBioSan Diego, United States1 insp.
Aaron R. Mangold, M.D.Scottsdale, United States1 insp.
Joanna Van, M.D.Tustin, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Samson O Oluseye3 shared
Andra Lepnis2 shared
Lan T Tran2 shared
Saaman Habibi1 shared
Jose A Leyva1 shared
Grace P Santos1 shared
Dustin R Abaonza1 shared
Humberto Z Gomez1 shared
Korina Serrano1 shared
Jasmine Y Wang1 shared
Full investigator report
Get the verbatim findings behind Farwa Z Razvi's 16 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site